Unknown

Dataset Information

0

Enhanced selective capture of phosphomonoester lipids enabling highly sensitive detection of sphingosine 1-phosphate.


ABSTRACT: Sphingolipids play crucial roles in cellular membranes, myelin stability, and signalling responses to physiological cues and stress. Among them, sphingosine 1-phosphate (S1P) has been recognized as a relevant biomarker for neurodegenerative diseases, and its analogue FTY-720 has been approved by the FDA for the treatment of relapsing-remitting multiple sclerosis. Focusing on these targets, we here report three novel polymeric capture phases for the selective extraction of the natural biomarker and its analogue drug. To enhance analytical performance, we employed different synthetic approaches using a cationic monomer and a hydrophobic copolymer of styrene-DVB. Results have demonstrated high affinity of the sorbents towards S1P and fingolimod phosphate (FTY-720-P, FP). This evidence proved that lipids containing phosphate diester moiety in their structures did not constitute obstacles for the interaction of phosphate monoester lipids when loaded into an SPE cartridge. Our suggested approach offers a valuable tool for developing efficient analytical procedures.

SUBMITTER: Grasso G 

PROVIDER: S-EPMC10567913 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Enhanced selective capture of phosphomonoester lipids enabling highly sensitive detection of sphingosine 1-phosphate.

Grasso Giuliana G   Sommella Eduardo M EM   Merciai Fabrizio F   Abouhany Rahma R   Shinde Sudhirkumar A SA   Campiglia Pietro P   Sellergren Börje B   Crescenzi Carlo C  

Analytical and bioanalytical chemistry 20230922 26


Sphingolipids play crucial roles in cellular membranes, myelin stability, and signalling responses to physiological cues and stress. Among them, sphingosine 1-phosphate (S1P) has been recognized as a relevant biomarker for neurodegenerative diseases, and its analogue FTY-720 has been approved by the FDA for the treatment of relapsing-remitting multiple sclerosis. Focusing on these targets, we here report three novel polymeric capture phases for the selective extraction of the natural biomarker a  ...[more]

Similar Datasets

| S-EPMC6523801 | biostudies-literature
| S-EPMC8864552 | biostudies-literature
| S-EPMC3912487 | biostudies-literature
| S-EPMC4616020 | biostudies-literature
| S-EPMC11436650 | biostudies-literature
| S-EPMC3786410 | biostudies-literature
| S-EPMC2935809 | biostudies-literature
| S-EPMC8747124 | biostudies-literature
| S-EPMC6714603 | biostudies-literature
| S-EPMC10527390 | biostudies-literature